浏览全部资源
扫码关注微信
武汉市普仁医院,武汉 430000)
李俊,硕士,主治医师,从事中医内科临床工作,E-mail:370507218@qq.com
*胡小军,硕士,副主任医师,从事中医老年病的临床工作,E-mail:493505911@qq.com
纸质出版日期:2019-02-20,
网络出版日期:2018-10-29,
收稿日期:2018-07-25,
扫 描 看 全 文
李俊, 胡小军, 王青, 等. 通窍活血汤加减联合“回阳九针”治疗卒中后认知障碍的临床观察[J]. 中国实验方剂学杂志, 2019,25(4):75-80.
Jun LI, Xiao-jun HU, Qing WANG, et al. Clinical Effect of Modified Tongqiao Huoxuetang Combined with 'Huiyang Jiuzhen’ in Treating Post-stroke Cognitive Impairment[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2019,25(4):75-80.
李俊, 胡小军, 王青, 等. 通窍活血汤加减联合“回阳九针”治疗卒中后认知障碍的临床观察[J]. 中国实验方剂学杂志, 2019,25(4):75-80. DOI: 10.13422/j.cnki.syfjx.20190431.
Jun LI, Xiao-jun HU, Qing WANG, et al. Clinical Effect of Modified Tongqiao Huoxuetang Combined with 'Huiyang Jiuzhen’ in Treating Post-stroke Cognitive Impairment[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2019,25(4):75-80. DOI: 10.13422/j.cnki.syfjx.20190431.
目的:
2
探讨通窍活血汤加减联合“回阳九针”治疗卒中后认知障碍(PSCI)的临床效果,并从抗炎、抗氧化应激和改善血液流变学方面观察了其作用机制。
方法:
2
将122例符合要求的患者随机分为对照组和观察组各61例。两组患者均口服盐酸多奈哌齐片,10 mg/次,1次/d;口服尼麦角林片,20 mg/次,3次/d。对照组采用“回阳九针”,1次/d,6次/周。观察组在对照组治疗的基础上给予通窍活血汤加减,1剂/d。两组疗程均为连续治疗8周。主要疗效指标采用简易智力状态检查量表(MMSE)和蒙特利尔认知评估量表(MoCA),分别于治疗前、治疗后4和8周各评价1次。次要指标包括治疗前后的日常生活能力(ADL),瘀阻脑络证评分;治疗前后白细胞介素-6(IL-6),C-反应蛋白(CRP),肿瘤坏死因子-
α
(TNF-
α
),氧化低密度脂蛋白(Ox-LDL),超氧化物歧化酶(SOD),丙二醛(MDA)水平的检测;和治疗前后血液流变学检测。
结果:
2
经秩和检验,观察组临床疗效优于对照组(
Z
=1.976,
P
<
0.05);在治疗后4和8周观察组患者的MMSE评分均高于对照组(
P
<
0.05),观察组MMSE评分上升的幅度多于对照组(
P
<
0.05);在治疗后4和8周观察组患者的MoCA评分均高于对照组(
P
<
0.05),观察组MoCA评分上升的幅度大于对照组(
P
<
0.05);观察组患者ADL和瘀阻脑络证评分均低于对照组(
P
<
0.01);观察组患者血清IL-6,TNF-
α
和CRP水平均低于对照组(
P
<
0.01);观察组MDA和Ox-LDL水平均低于对照组,SOD水平高于对照组(
P
<
0.01);观察组全血黏度(高切、低切)、血浆黏度、红细胞聚集指数、血小板聚集性、纤维蛋白原和血沉等血液流变学指标均低于对照组(
P
<
0.01)。
结论:
2
在西医常规治疗的基础上,通窍活血汤联合“回阳九针”治疗PSCI患者,能提高患者的认知功能和日常生活能力,并具有抗炎、抗氧化和改善血液流变学作用,有利于促进认知功能的恢复。
Objective:
2
To discuss the clinical efficacy of modified Tongqiao Huoxuetang combined with 'Huiyang Jiuzhen' in treating post-stroke cognitive impairment (PSCI) and its mechanisms in resisting inflammation and oxidant stress and ameliorating hemorheology.
Method:
2
One hundred and twenty-two patients were randomly divided into control group (61 cases) and observation group (61 cases) by random number table. Both groups got Donepezil tablets
10 mg/time
1 time/day
and Nicergoline tablets
20 mg/time
3 times/days. Patients in control group got 'Huiyang Jiuzhen'
1 time/day
6 times/week. In addition to the therapy in control group
patients in observation group got modified Tongqiao Huoxuetang
1 dose/day. And a course of treatment was 8 weeks. Before treatment and at the 4
th
week and 8
th
week after treatment
scores of mini-mental state examination (MMSE) and Montreal cognitive assessment (MoCA) were discussed. And activity of daily living scale (ADL)
syndrome of blood stasis and cerebral collaterals were graded. And levels of Interleukin-6 (IL-6) before and after treatment
C-reactive protein (CRP)
tumor necrosis factor-
α
(TNF-
α
)
oxidized low density lipoprotein (Ox-LDL)
superoxide dismutase (SOD)
malondialdehyde (MDA)
hemorheology were detected.
Result:
2
According to the rank sum test
the clinical efficacy in observation group was better than that in control group (
Z
=1.976
P
<
0.05). At the 4
th
week and 8
th
week after treatment
score of MMSE and MoCA were higher than that in control group (
P
<
0.05)
and the extent of the rise were more than that in control group (
P
<
0.05). And scores of ADL and syndrome of blood stasis and cerebral collaterals were lower than those in control group (
P
<
0.01). Levels of IL-6
TNF-
α
CRP
DA and Ox-LDL were lower than those in control group (
P
<
0.01)
and level of SOD was higher than that in control group (
P
<
0.01). Levels of whole blood viscosity (high-cut
low-cut)
plasma viscosity
erythrocyte aggregation index
platelet aggregation
fibrinogen and erythrocyte sedimentation rate (ESR) were lower than those in control group (
P
<
0.01).
Conclusion:
2
In addition to the routine therapy of western medicine
modified Tongqiao Huoxuetang combined with 'Huiyangjiuzhen' can improve patients cognitive function and daily life ability
have effects in resisting inflammation and oxidation and ameliorating hemorheology
and can promote the recovery of cognitive function.
卒中后认知障碍瘀阻脑络证通窍活血汤“回阳九针”抗炎抗氧化血液流变学
post-stroke cognitive impairmentpost-stroke cognitive impairmentTongqiao HuoxuetangHuiyang Jiuzhenanti-inflammatoryanti-oxidationhemorheology
熊键, 廖维靖, 刘琦,等. 头针治疗脑卒中后认知功能障碍的系统评价[J].中国康复医学杂志, 2016, 31(3):333-339.
Mozaffarian D, Benjamin E J, Go A S, et al. Heart disease and stroke statistics—2015 update: a report from the american heart association[J].Circulation, 2015, 131(4):e29-e322.
中国卒中学会. 卒中后认知障碍管理专家共识[J].中国卒中杂志, 2017,12(6):519-531.
程蕊容, 辛秀峰, 刘章佩,等. 卒中后认知障碍的研究进展[J].临床荟萃, 2018, 33(1):89-92.
香兰, 李涛, 贾蓓,等. 中医综合干预方案对卒中后轻度认知功能障碍疗效评价[J].中华中医药杂志, 2016,31(6):2129-2132.
胡小军, 余长江, 沈玉杰,等. 针刺回阳九针穴对中风后遗症患者脑血流的影响[J].湖北中医药大学学报, 2017, 19(1):78-80.
李俊, 王珊, 陈瑶,等. 针刺回阳九针穴联合加味补中益气汤治疗急性脑梗死的疗效观察[J].世界中医药, 2017, 12(2):398-400.
胡小军, 余长江, 李俊,等. 回阳九针联合中药通窍活血汤加减治疗老年性痴呆精神行为症状疗效观察[J].现代中西医结合杂志, 2015,24(28):3124-3126.
王鑫铭, 葛朝亮, 黄赵刚,等. 通窍活血汤对血管性痴呆大鼠海马组织乙酰胆碱酯酶和胆碱乙酰转移酶含量的影响[J].中国新药杂志, 2015,24(2):204-207.
卢昌均, 安红伟, 刘国成,等. 通窍活血汤治疗血管性痴呆的临床研究[J].河北中医, 2012, 34(2):171-173.
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014 [J].中华神经科杂志,2015,48(4): 246-257.
田金洲, 时晶, 张新卿,等. 轻度认知损害临床研究指导原则(草案)[J].中西医结合学报, 2008, 6(1):9-14.
王若丹,李国春.健脑灵片联合复方银杏通脉口服液治疗血管性认知障碍45例[J].中国实验方剂学杂志,2015,21(19):181-184.
张淼,武文鹏,夏昆鹏,等.卒中得生丸联合原络通经针法治疗卒中后认知障碍的临床分析[J].中国实验方剂学杂志,2108,24(20):186-191.
靳林静, 范云龙, 于文涛. 血管性痴呆中医证候研究概况[J].中西医结合心脑血管病杂志, 2016, 14(2):152-154.
周斌, 张钟爱. 从《医林改错》谈老年性痴呆的中医治疗[J].吉林中医药, 2007, 27(10):59-60.
李欧,吴双,沙中玮,等.血管性认知功能障碍中医药治疗研究进展[J].现代中西医结合杂志,2018(20):2269-2272.
葛朝亮, 王鑫铭, 余剑萍,等. 通窍活血汤对血管性痴呆大鼠血液流变学的影响[J].中成药, 2015, 37(8):1641-1646.
孟胜喜, 霍清萍. 地龙及其有效成分对神经系统疾病的作用[J].山东中医杂志, 2016,35(10):933-936.
赵蕾, 吴晓光, 杜娈英,等. 山楂叶总黄酮对血管性痴呆大鼠海马谷氨酸和NMDA受体表达的影响[J].广东医学, 2014, 35(3):353-356.
林晨, 安红梅. 石菖蒲的中枢神经系统药理作用研究[J].长春中医药大学学报, 2014, 30(2):230-233.
刘增玲, 李文, 李海龙,等. 血管性认知功能障碍非痴呆型患者外周血炎性标记物的临床研究[J].中国临床神经科学, 2013, 21(1):32-36.
展翔, 李坤彬, 王东伟. 丹参多酚酸盐联合灯盏生脉胶囊对缺血性脑卒中神经功能缺损程度及血液流变学的影响[J].广东医学, 2017, 38(16):2555-2557.
0
浏览量
7
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构